Drug Search Results
More Filters [+]

GR-270774

Alternative Names: gr-270774, gr270774, gr 270774
Latest Update: 2010-07-07
Latest Update Note: Clinical Trial Update

Product Description

For the Treatment of Gram-negative Sepsis (Sourced from: https://clinicaltrials.gov/ct2/show/NCT00563134)

Mechanisms of Action: Gram- Bacteria Reducer

Novel Mechanism: Yes

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Hospital Authority, Hong Kong
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for GR-270774

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

KW/FR/04-018

N/A

Suspended

Sepsis|Gram-Negative Bacterial Infections

None

Recent News Events

Date

Type

Title